This is the latest installment in a new series where BioPharma Dive uses data visualization...
BREMEN, Germany — mzio GmbH announces the launch of mzassist, a vendor-neutral AI and automation control...
Artiva Biotherapeutics will lay off most of its staff and stop developing an experimental “natural...
Sponsored content By Cencora SPONSORED CONTENT BY International reference pricing has been a talking point...
With quarterly earnings underway, BioPharma Dive is providing a snapshot of some companies’ results and...
Today, a brief rundown of news involving Eli Lilly and Novartis, as well as updates...
Ferring Pharmaceuticals has agreed to buy fertility treatment startup Gameto in a potentially $1.4 billion...
With quarterly earnings underway, BioPharma Dive is providing a snapshot of some companies’ results and...
Two months after Actio Biosciences sold some of its assets to Jazz Pharmaceuticals , the...
Dive Brief: An experimental drug that Genmab gained in an $8 billion buyout succeeded...
First published on The Keytruda biosimilars are coming. In October, the FDA accepted the...
Dive Brief: Eli Lilly’s triple-acting metabolic drug retatrutide bested Novo’s Ozempic in a head-to-head...
The biotechnology startup creator Flagship Pioneering is rolling three of its fledgling companies into a...
Dive Brief: A federal judge denied Novo’s request to block an Eli Lilly advertising...
Dive Brief: Health and Human Services Secretary Robert F. Kennedy Jr. on Wednesday adopted...
